-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dh17Z7DHlLz1gr5ftTsUgv/GzM58YXqmkkXbpgHP/nCguMAjQE25h4qSzCtOTacw bbIqkaahdL3tNNg1u8A+cQ== 0001104659-09-016187.txt : 20090311 0001104659-09-016187.hdr.sgml : 20090311 20090310175343 ACCESSION NUMBER: 0001104659-09-016187 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20090310 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20090311 DATE AS OF CHANGE: 20090310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NBTY INC CENTRAL INDEX KEY: 0000070793 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112228617 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31788 FILM NUMBER: 09670691 BUSINESS ADDRESS: STREET 1: 90 ORVILLE DR CITY: BOHEMIA STATE: NY ZIP: 11716 BUSINESS PHONE: 5165679500 MAIL ADDRESS: STREET 1: 90 ORVILLE DRIVE CITY: BOHEMIA STATE: NY ZIP: 11716 FORMER COMPANY: FORMER CONFORMED NAME: NATURES BOUNTY INC DATE OF NAME CHANGE: 19920703 8-K 1 a09-7423_18k.htm 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K
 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  March 10, 2009
 

NBTY, INC.

 (Exact Name of Registrant as Specified in Charter)

 

001-31788

(Commission File Number)

 

DELAWARE

 

11-2228617

(State or Other Jurisdiction

 

(I.R.S. Employer

of Incorporation)

 

Identification No.)

 

 

 

2100 Smithtown Avenue

 

11779

Ronkonkoma, New York

 

(Zip Code)

(Address of Principal Executive Offices)

 

 

 

(631) 567-9500

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

 

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))

 

 

 

 

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

ITEM 7.01.            REGULATION FD DISCLOSURE

 

On March 10, 2009 NBTY, Inc. issued a press release announcing preliminary unaudited sales results for the month of February 2009.  A copy of the press release is attached as Exhibit 99.1.

 

ITEM 9.01.            FINANCIAL STATEMENTS AND EXHIBITS

 

(d)         Exhibits.

 

99.1 Press release issued by NBTY, Inc., dated March 10, 2009

 

This Form 8-K and the attached Exhibit are furnished to comply with Item 7.01 and Item 9.01 of Form 8-K.  Neither this Form 8-K nor the attached Exhibit are to be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall this Form 8-K nor the attached Exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933 (except as shall be expressly set forth by specific reference in such filing).

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated:  March 10, 2009

 

 

NBTY, INC.

 

 

 

 

 

By:

/s/ Harvey Kamil

 

 

 Harvey Kamil

 

 

 President and Chief Financial Officer

 

 

3


EX-99.1 2 a09-7423_1ex99d1.htm EX-99.1

Exhibit 99.1

 

Public Relations

 

 

470 Park Avenue South, New York, NY 10016 (212) 725-4500

 

NEWS

 

 

 

Contact: Harvey Kamil

 

Carl Hymans

NBTY, Inc.

 

G.S. Schwartz & Co.

President & Chief Financial Officer

 

212-725-4500

631-200-2020

 

carlh@schwartz.com

 

NBTY TO WEBCAST PRESENTATION AT B. RILEY & CO.

ANNUAL LAS VEGAS INSTITUTIONAL INVESTOR CONFERENCE

-ANNOUNCES PRELIMINARY UNAUDITED NET SALES RESULTS FOR FEBRUARY 2009-

 

RONKONKOMA, N.Y. — March 10, 2009 - NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced that it will webcast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the B. Riley & Co. Annual Las Vegas Institutional Investor Conference on Wednesday, March 18, 2009.

 

The presentation is scheduled to be webcast live on the Company Web site, www.nbty.com, on Wednesday, March 18, 2009 at 1:00PM Pacific Time (4:00PM Eastern Time).

 

NBTY’s preliminary unaudited net sales results for February 2009 by segment are as follows:

 

NET SALES

(Preliminary and Unaudited)

FOR THE MONTH OF FEBRUARY

($ In Millions)

 

 

 

2009

 

2008

 

% Change

 

 

 

 

 

 

 

 

 

Wholesale / US Nutrition

 

$

111

 

$

81

 

38

%

 

 

 

 

 

 

 

 

North American Retail

 

$

17

 

$

17

 

1

%

 

 

 

 

 

 

 

 

European Retail

 

$

42

 

$

51

 

-18

%

 

 

 

 

 

 

 

 

Direct Response / E-Commerce

 

$

17

 

$

19

 

-10

%

 

 

 

 

 

 

 

 

Total

 

$

187

 

$

168

 

12

%

 



 

Wholesale / US Nutrition net sales for the month of February 2009 include $33 million from Leiner which was acquired in July 2008.  Without Leiner sales, the Wholesale / US Nutrition net sales would have decreased 3% for the one-month period.  North American Retail same store sales increased 2% for the one month period.  European Retail net sales for February 2009 include $7 million from Julian Graves, which NBTY acquired in September 2008.  Excluding Julian Graves sales, European Retail net sales decreased 8% in local currency (British Pound Sterling), and 32% in US dollars for the period.

 

NBTY’s preliminary unaudited net sales results for the two months January and February 2009 by segment are as follows:

 

NET SALES

(Preliminary and Unaudited)

FOR THE TWO MONTHS OF JANUARY AND FEBRUARY

($ In Millions)

 

 

 

2009

 

2008

 

% Change

 

 

 

 

 

 

 

 

 

Wholesale / US Nutrition

 

$

220

 

$

164

 

34

%

 

 

 

 

 

 

 

 

North American Retail

 

$

34

 

$

34

 

1

%

 

 

 

 

 

 

 

 

European Retail

 

$

88

 

$

107

 

-18

%

 

 

 

 

 

 

 

 

Direct Response / E-Commerce

 

$

38

 

$

40

 

-6

%

 

 

 

 

 

 

 

 

Total

 

$

380

 

$

346

 

10

%

 

Wholesale / US Nutrition net sales for the two-month period of January and February 2009 include $59 million from Leiner which was acquired in July 2008.  Without Leiner sales, the Wholesale / US Nutrition net sales would have decreased 2% for the two-month period.  North American Retail same store sales increased 2% for the two-month period.  European Retail net sales for the two-month period of January and February 2009 include $15 million from Julian Graves, which NBTY acquired in September 2008.  Excluding Julian Graves sales, European Retail net sales decreased 8% in local currency (British Pound Sterling), and 32% in US dollars for the two-month period.

 

ABOUT NBTY

 

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company’s Nature’s Bounty® (www.NaturesBounty.com), Vitamin World® www.VitaminWorld.com), Puritan’s Pride® (www.Puritan.com), Holland & Barrett® (www.HollandAndBarrett.com), Rexall® (www.Rexall.com), Sundown® (www.SundownNutrition.com), MET-Rx® (www.MetRX.com), Worldwide Sport Nutrition® (www.SportNutrition.com), American Health® (www.AmericanHealthUS.com), GNC (UK)® (www.GNC.co.uk), DeTuinen® (www.DeTuinen.nl), LeNaturiste™ (www.LeNaturiste.com), SISU® (www.SISU.com), Solgar® (www.Solgar.com), Good ‘n’ Natural® (www.goodnnatural.com), Home Health™ (www.homehealthus.com), Julian Graves, and Ester-C® (www.Ester-C.com) brands.  NBTY routinely posts information that may be important to investors on its web site.

 


GRAPHIC 3 g74231mmi001.jpg GRAPHIC begin 644 g74231mmi001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H`"`$!```_`/9J*HW6M:;93&&XNXUD`R4&6(^H'2K23Q20"=)%,3+N M#YXQZU6M=8TZ]G\FVNDE?!("YY`]#WJ[11111111112'.#C@]JY;P_?VFD6< MUGJ;+:7RR.TS3#'G9)(8'^(8JU8:Q;:IHFW42L1GBD)CC5AF,$@D?A6?IVJG M2KR"SBU"/4=,6-B9=GSVR@<9(X([>M=;'(DL2R1G(M*L;G[ M+,S3W`Y,,,1E9?J!TIB>*=+;3IKXF:.*W8)()(65E)Z<8K4CEB>U$Z*=CIOQ MMY(QGI68GBK2GM8+H2R"">;R4U7=2U2UTFW6XO'*1LX3N6&CB`WLIC$YPGRD_GZ=:N2S)%`\S9*(I8[1 MG@5CP^,-'F\MO,FCCE.U)9(65"?][&*=>>*M-L7=9UN0J/L+B!BA/L<8-2+X MCLVB:007HVL%VFV<,Q.>@QSTJ.#Q583ZA%8"*[2XE^ZDENR\>O/;WK:K+\0: M)'KVG?96F:"17$D4BC.UATX[UD0ZYK.CZC;:9KL,,ZW3%(+R#C9=\CQG'1U;(Q^7ZU"TLGC6VLK$.Q\JW:6?G&V0?* MH/XY-6M,U!M=CT?2I#F2V9GO%/;R^%!^IQ1J,=]X@U&^DM]-%W:(AM(G,RH` M?XF&>O..?:M+P[?S7?ABXM+L%;RP5X)E)YX!P?R_E7-69DET+2++4"L&DW1^ M>=1D[@QPI/10?6NF\;!5\/Q!?NBYB`^F:V=2UM/EO;EL1Q+G'=CV`]S67 MXW@R$/\`RQC[*/ZUO54U'38=3A6.5Y8RC;E>&0HRGZBJUKX> ML[>\2\DDN+NXC!$[9;:Z/6:VD,;-]<=:C/A33WL M9[2:6[G6X(\QY9RSD#D#/85K1P+':K;JS;538"3SC&.M5M)TNUTBS^RV9,^WI4=OHFG6][>W5L#'/>#$I1^1[C MT-6=.T^#2[)+2V#"),XW')Y.>M5_[#LDO;N]!E22[39-B3`88QT]?>G0:)I\ M.D?V4(O,L\$;)&W<$YZU%+X=L)]-CTZ7SGMXW#HIE;((Z<]<"I-4T.RUB"*& M^622.(Y4"0KD^IQUJLOA32P5R+EPI!VOV:V:6BBBJ6L74=EH]W<2[]B M1-GR^&Z8XKFO#%Q_8LYM-6=(9;Q4:!U8>4X`Z9_O\\^M:WBN>2#2XB)'B@>X M1+B1#@K&3R<]OK1%W9!R-+"`)(,,I0$$>E65MX5@^SB-?*`V[",C'I5 M:WT73+24RP6,,;D$9"]CU%.ATC3H-_E64*>8I5L(.0>H^E3FV@:V^RF%#!MV M>7CY=OICTIJV5JA8K;Q@N@C8A>JCH/I4>!R\4$:,5"DJH!('0?A4U%%%%%%%%%%%%%%%%?_9 ` end
-----END PRIVACY-ENHANCED MESSAGE-----